IL1B and cancer: The results of our study showing a significant decrease in the mean IL-1 beta levels within the fourth week of 30-day DDDF and within two weeks after 30-day DDDF suggest that DDDF can be considered an adjunct treatment in several cancers, and further studies are needed.